CMAST attends the 2nd General Assembly of RESCEU; a European project focusing on the battle against RSV (June 21st-22nd, Oxford - UK)


In support of Janssen, CMAST – a leading consultancy and project management company in life sciences - is attending the 2nd RESCEU General Assembly on June 21st and 22nd in Oxford, UK. RESCEU is a European project – funded by IMI – that focuses on the fight against Human Respiratory Syncytial Virus (RSV), the most common cause of severe respiratory illness in infants and children worldwide. CMAST contributes to this project by providing project management services.

RSV was estimated to be associated with 34 million cases of acute lower respiratory tract infection (ALRI), 3.4 million ALRI hospitalisations and 55,000 to 199,000 deaths in children <5 years in 2005.
Today, there is no specific treatment or vaccine for RSV. RESCEU aims to develop robust evidence on RSV disease burden and its economic impact, which will help to increase early diagnosis, and to develop new treatments and vaccines.
RESCEU’s vision is to integrate and exploit existing knowledge and data to provide greater insights into the impact of RSV on health systems and societies throughout Europe, and to actively engage stakeholders in order to improve strategic planning and decision-making. It also seeks to access existing clinically annotated biological specimens from prospective studies and to supplement this with bespoke clinical studies to create a powerful new bio-repository for future research.
The RESCEU project brings together 56 partners from academia, public health, scientific societies, patient organisations, regulatory agencies and industry throughout Europe.
The project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement Nº 116019. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
More info about this project can be found on


CMAST is a leading consultancy and project management company in life sciences.

With a team of more than 90 industry experts, CMAST provides support to pharma and life sciences companies, universities and research institutes.

The company offers consultancy, project management and tangible business solutions in the following areas:

  • Early stage innovation services
  • Funding services
  • Project & Portfolio Management
  • R&D process optimization
  • Multi-stakeholder collaborations
  • Regulatory compliance & quality
  • Health data analytics & visualization
  • Supply chain

CMAST is headquartered in Temse (Belgium) and has branches in Switzerland, Germany, Poland and the US. Since 2018 CMAST is part of Modis Life Sciences, a subdivision of The Adecco Group, which gives the company a global reach.

More info on


Interested in a regular update of the Life Sciences and biotech sector in Flanders?